Page 9 - April 2026 Insider

•
INSIDER April 2026

Page 9
ARCS Scholars & Scholar Alumni Making

Headlines… Continued from Page 8

Brandon Vogt (2025-2026 ARCS Scholar at UC San Diego) was
one of two keynote speakers for the ARCS Forward National Event on
April 14th, which focused on Women and Children’s Heart Health.
Brandon is a PhD candidate in Bioengineering in Brian Aguado’s lab at UC
San Diego, where he conducts research in sex differences. He develops
sex-specific predictive models to pinpoint synergistic drug interactions,
leverages proteomics to identify individualized biomarkers, and designs
high-throughput hydrogel biomaterial platforms for anti-fibrotic drug

optimization.

You can find the full 1-hr recording of this ARCS Forward National event
here: https://arcsfoundation.org/get-involved/arcs-forward

Dena Marrinucci, PhD (2008-2009 ARCS Scholar at Scripps
Research) was featured in The San Diego Union-Tribune for her
groundbreaking work as co-founder and Chief Operating Officer of
Truvian, a San Diego biotech company that has developed a device
capable of delivering 26 different blood tests in just 30 minutes using
only eight drops of blood, and recently earned FDA clearance!

Dena's work is a perfect example of the innovative, real-world science
that ARCS Scholars pursue. We couldn't be more proud of Dena and the
Truvian team for turning a vision into reality!

Read the full article here:
https://www.sandiegouniontribune.com/2026/02/19/san-diego-
company-invents-a-30-minute-blood-test-will-it-ever-come-to-market/

Scholar Alumni – Where Are They Now?

Suzy Pritchett Benedict, MS (1997, SDSU) is currently Senior
Vice President at Aditum Bio, a biotech venture capital company
based in Oakland, California, although Suzy resides in Encinitas.

Suzy has over 20 years of experience in the pharmaceutical industry
and has held positions of increasing seniority in Medicinal Chemistry,
Regulatory Chemistry, Manufacturing and Controls (CMC) and
Regulatory Affairs.

Prior to joining Aditum Bio, Suzy served as Executive Vice President,
Regulatory Affairs at TRACON Pharmaceuticals, where she oversaw Continued on Page 10